Public company info
Input the stock code or the company name     Search  
 


 Stock code   06855 
 Company name  Ascentage Pharma Group International
 Region  Hong Kong
 Type  MB
 Website  
 Quote  0.0 

Company profile  |  Business review  |  Prospect  |  Latest results  |  Financial ratios
Income statement  |  Cash flow statement  |  Balance sheet  |  Entitlement
Disclosure of interest  |  Quote

 Related stock news
  亞盛醫藥擬按市價發售最多2億美元美國...  2026-07-20T  
  亞盛醫藥擬在美按市價發售ADS 集資...  2026-07-20T  
  亞盛醫藥六項研究入選美國臨床腫瘤學會...  2026-05-22T  
  亞盛醫藥多項研究入選2026 ASC...  2026-04-22T  
  《大行》摩通降亞盛醫藥目標價至89元...  2026-04-21T  
  亞盛醫藥四項臨床前進展將於今年美國癌...  2026-04-20T  
  《業績》亞盛醫藥去年虧損擴大至12....  2026-03-26T  
  亞盛醫藥將於美國癌症研究協會年會公布...  2026-03-18T  
  亞盛醫藥新藥「奧雷巴替尼」全球註冊三...  2025-12-05T  
  亞盛醫藥發布耐立克等多項產品臨床進展  2025-11-04T  
  Search   More 
 Latest News
  南向資金今日淨賣出超106億 港元 ...  2026-08-19T17:  
  ...瑞銀:黃金中期漲勢未完 預計明...  2026-08-19T17:  
  騰訊斥約3億元回購67.3萬股  2026-08-19T  
  《業績》冠君產業信託中期扭虧賺5.4...  2026-08-19T  
  紐約匯市: 美元 隨油價上漲 日元 ...  2026-08-19T05:  
  A50 增強 ETF 富國(5632...  2026-08-19T03:  
  Search   More 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.